Kenneth A Clark insider trades

Open-market stock purchases and sales by Kenneth A Clark, Director at Summit Therapeutics Inc, from SEC Form 4 filings since Nov 9, 2012.

Recent trades

DateStockTradeValue
Jan 2, 2026SMMT Summit Therapeutics IncBought (not open market)$613K
Jan 2, 2026SMMT Summit Therapeutics IncBought (not open market)$156K

Companies traded

  • SMMT Summit Therapeutics Inc: other filings, last Jan 2, 2026
  • PLSE Pulse Biosciences, Inc: other filings, last May 20, 2021
  • PCYC Pharmacyclics Inc: other filings, last May 26, 2015

Get free alerts when Kenneth A Clark files a new trade →